Trial intelligence / Profile preview

Vitamins B6 and B12 for Chemotherapy-Induced Neuropathy

NCT00659269Phase 3Completed

Sponsor
New Mexico Cancer Research Alliance
Start
Jul 2006
Primary completion
Jun 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of pyridoxine, cyanocobalamin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by New Mexico Cancer Research Alliance. Started Jul 2006; status: completed.

02

Drugs

pyridoxinecyanocobalamin
03

Conditions

chemotherapy-induced peripheral neuropathy (CIPN)

Beyond the preview

Go deeper on NCT00659269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00659269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call